title: Early changes of neuromuscular transmission in the SOD1(G93A) mice model of ALS start long before motor symptoms onset.
abstract: Amyotrophic lateral sclerosis is characterized by a progressive degeneration of the corticospinal tract motor neurons. Growing evidence suggests that degeneration may begin at the distal axon proceeding in a dying-back pattern. It seemed therefore of interest to investigate synaptic transmission at the neuromuscular junction (NMJ) in pre- and symptomatic phases of the disease. Endplate potentials (EPPs), miniatures endplate potentials (MEPPs) and giant MEPPs (GMEPPs) were recorded from innervated diaphragm muscle fibers from 4-6 and 12-15 weeks-old SOD1(G93A) mice and non-transgenic aged-matched littermates (WT). In the pre-symptomatic phase, SOD1(G93A) mice exhibited a significant increase in the mean amplitude of EPPs together with an increase in the mean quantal content of EPPs, suggesting that more acetylcholine is being released into the synaptic cleft. SOD1(G93A) mice presented a higher frequency of GMEPPs, suggestive of intracellular Ca(2+) deregulation in nerve terminals. The increase in the mean amplitude of MEPPs and the decreased mean rise-time of MEPPs in SOD1(G93A) mice point to post-synaptic related changes. In the symptomatic phase, electrophysiological data showed evidence for two NMJ groups in SOD1(G93A) mice: SOD1a and SOD1b. SOD1a group presented reduced mean amplitude of both EPPs and MEPPs. The mean rise-time of MEPPs was increased, when compared to WT and to SOD1b group, indicating impairments in the neuromuscular transmission. In contrast, the neuromuscular transmission of SOD1b group was not different from age-matched WT nor pre-symptomatic SOD1(G93A) mice, being somehow in between both groups. Altogether these results show that the neuromuscular transmission of SOD1(G93A) mice is enhanced in the pre-symptomatic phase. In the symptomatic phase our results are consistent with the hypothesis that the diaphragm of SOD1(G93A) mice is undergoing cycles of denervation/re-innervation supported by mixed neuromuscular junction populations. These early changes in the neuromuscular transmission of SOD1(G93A) mice suggest that the ALS associated events start long before symptoms onset.
authors.affiliation: Institute of Pharmacology and Neurosciences, Faculty of Medicine, University of Lisbon, Lisbon, Portugal ; Unit of Neurosciences, Institute of Molecular Medicine, University of Lisbon, Lisbon, Portugal.
authors.forename: Mariana C
authors.initials: MC
authors.lastname: Rocha
authors.forename: Paula A
authors.initials: PA
authors.lastname: Pousinha
authors.forename: Alexandra M
authors.initials: AM
authors.lastname: Correia
authors.forename: Ana M
authors.initials: AM
authors.lastname: Sebastião
authors.forename: Joaquim A
authors.initials: JA
authors.lastname: Ribeiro
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000235:genetics / Q000473:pathology / Q000503:physiopathology*; D000818:Animals; D003964:Diaphragm / Q000294:innervation / Q000378:metabolism; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D009043:Motor Activity / Q000235:genetics / Q000502:physiology; D018482:Muscle, Skeletal / Q000294:innervation / Q000378:metabolism; D009469:Neuromuscular Junction / Q000378:metabolism / Q000502:physiology*; D013482:Superoxide Dismutase / Q000235:genetics / Q000378:metabolism*; D055366:Synaptic Potentials / Q000235:genetics / Q000502:physiology; D009435:Synaptic Transmission / Q000235:genetics / Q000502:physiology*; D013997:Time Factors
chemical_list: C109415:SOD1 G93A protein; D013482:Superoxide Dismutase
references.citation: J Physiol. 1981 Nov;320:435-47
references.pmid: 7320945
references.citation: Brain Res. 2006 May 17;1089(1):126-34
references.pmid: 16631140
references.citation: J Physiol. 1987 Mar;384:571-85
references.pmid: 2821240
references.citation: Brain Res. 1983 Mar 28;264(1):89-97
references.pmid: 6133583
references.citation: Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):2007-11
references.pmid: 19174508
references.citation: J Comp Neurol. 2005 Sep 26;490(3):209-19
references.pmid: 16082680
references.citation: J Neurosci. 2010 Jan 20;30(3):849-57
references.pmid: 20089893
references.citation: J Pharmacol Exp Ther. 2006 Dec;319(3):1009-20
references.pmid: 16982704
references.citation: J Physiol. 1978 Jan;274:51-62
references.pmid: 203677
references.citation: Brain Res Brain Res Protoc. 1997 Dec 1;2(1):75-84
references.pmid: 9438075
references.citation: J Biol Chem. 2010 Jan 1;285(1):705-12
references.pmid: 19889637
references.citation: J Physiol. 2008 Jul 15;586(14):3337-51
references.pmid: 18467368
references.citation: J Anat. 1969 May;104(Pt 3):519-30
references.pmid: 5804561
references.citation: Neurol Int. 2009 Nov 16;1(1):e16
references.pmid: 21577353
references.citation: Science. 1994 Jun 17;264(5166):1772-5
references.pmid: 8209258
references.citation: Nature. 1993 Mar 4;362(6415):59-62
references.pmid: 8446170
references.citation: Neuromuscul Disord. 2006 Mar;16(3):168-77
references.pmid: 16483776
references.citation: Neurobiol Dis. 2007 Nov;28(2):154-64
references.pmid: 17766128
references.citation: BMC Neurosci. 2009 Jun 22;10:64
references.pmid: 19545440
references.citation: J Neurosci. 2000 Apr 1;20(7):2534-42
references.pmid: 10729333
references.citation: Exp Neurol. 2004 Feb;185(2):232-40
references.pmid: 14736504
references.citation: J Neurochem. 2006 Mar;96(5):1349-61
references.pmid: 16478527
references.citation: J Physiol. 1960 Jan;150:145-68
references.pmid: 13800902
references.citation: J Physiol. 1960 Nov;154:190-205
references.pmid: 13770626
references.citation: J Physiol. 1990 Nov;430:399-418
references.pmid: 1707969
references.citation: J Neurosci. 2006 Mar 8;26(10):2661-72
references.pmid: 16525045
references.citation: Prog Neurobiol. 2001 Jul;64(4):393-429
references.pmid: 11275359
references.citation: J Biol Chem. 1985 Aug 5;260(16):9280-8
references.pmid: 2410412
references.citation: Ann Neurol. 2003 Feb;53(2):267-70
references.pmid: 12557297
references.citation: Proc R Soc Lond B Biol Sci. 1982 Apr 22;215(1198):63-74
references.pmid: 6127697
references.citation: Neuron. 2006 Oct 5;52(1):39-59
references.pmid: 17015226
references.citation: Br J Pharmacol. 1975 Jun;54(2):213-8
references.pmid: 167894
references.citation: J Neurosci. 2011 Jan 19;31(3):1106-13
references.pmid: 21248135
references.citation: Nat Rev Neurol. 2011 Nov;7(11):616-30
references.pmid: 22051914
references.citation: PLoS One. 2012;7(4):e34640
references.pmid: 22485182
references.citation: J Physiol. 1980 Oct;307:453-64
references.pmid: 7205674
references.citation: Pflugers Arch. 1996 Jan;431(3):325-34
references.pmid: 8584425
references.citation: Neuromuscul Disord. 2005 May;15(5):377-88
references.pmid: 15833433
references.citation: Neurobiol Aging. 2012 Dec;33(12):2869-80
references.pmid: 22365485
references.citation: Front Cell Neurosci. 2011 Dec 12;5:26
references.pmid: 22180738
references.citation: Exp Neurol. 2011 Sep;231(1):30-7
references.pmid: 21620832
references.citation: Stem Cell Rev Rep. 2012 Mar;8(1):224-8
references.pmid: 21678037
references.citation: J Neurosci. 1998 May 1;18(9):3241-50
references.pmid: 9547233
references.citation: Physiol Res. 2004;53(5):541-8
references.pmid: 15479133
references.citation: Hum Mol Genet. 2009 Mar 1;18(5):942-55
references.pmid: 19088126
references.citation: Nat Rev Neurosci. 2005 Jan;6(1):57-69
references.pmid: 15611727
references.citation: J Physiol. 2002 Sep 15;543(Pt 3):739-55
references.pmid: 12231635
references.citation: Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Mar;1 Suppl 1:S43-6
references.pmid: 11464925
references.citation: J Physiol. 2003 Jun 15;549(Pt 3):719-28
references.pmid: 12717010